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Nitric  oxide  (NO), hydrogen  sulﬁde  and  polysulﬁdes  have  been  proposed  to contribute  to  redox  signaling
by  activating  the Keap-1/Nrf2  stress  response  system.  Nitrosopersulﬁde  (SSNO−)  recently  emerged  as a
bioactive product  of the  chemical  interaction  of NO  or nitrosothiols  with  sulﬁde;  upon  decomposition  it
generates  polysulﬁdes  and  free  NO,  triggering  the  activation  of  soluble  guanylate  cyclase,  inducing  blood
vessel relaxation  in  vitro  and  lowering  blood  pressure  in  vivo.  Whether  SSNO− itself  interacts  with  the
Keap-1/Nrf2  system  is unknown.  We  therefore  sought  to  investigate  the  ability  of  SSNO− to  activate  Nrf2-
dependent  processes  in  human  vascular  endothelial  cells,  and  to  compare  the pharmacological  effects
of SSNO− with  those  of  its precursors  NO and  sulﬁde  at  multiple  levels  of  target  engagement.  We  here
demonstrate  that SSNO− strongly  increases  nuclear  levels,  binding  activity  and  transactivation  activity  of
Nrf2, thereby  increasing  mRNA  expression  of Hmox-1,  the  gene  encoding  for  heme  oxygenase  1, without
adversely  affecting  cell  viability.  Under  all  conditions,  SSNO− appeared  to  be  more  potent  than  its  parent
compounds,  NO  and  sulﬁde.  SSNO−-induced  Nrf2  transactivation  activity  was  abrogated  by  either  NO
scavenging  with  cPTIO  or  inhibition  of thiol  sulfuration  by high  concentrations  of cysteine,  implying  a role
−for  both  persulﬁdes/polysulﬁdes  and NO  in SSNO mediated  Nrf2  activation.  Taken  together,  our  studies
demonstrate  that the Keap-1/Nrf2  redox  system  is  a  biological  target  of SSNO−, enriching  the  portfolio
of bioactivity  of  this  vasoactive  molecule  to also  engage  in  the  regulation  of redox signaling  processes.
The  latter  suggests  a  possible  role  as  messenger  and/or  mediator  in cellular  sensing  and  adaptations
processes.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Hydrogen sulﬁde (H2S), a malodorous gas known to be toxic
hen inhaled, has recently been shown to exert a variety ofnteresting pharmacological actions including smooth muscle
elaxant effects [1–4]. It is also produced endogenously in the
ourse of sulfur-containing amino acid metabolism by enzymes of
Abbreviations: Hmox1, heme oxygenase-1; Keap-1, Kelch-like ECH-associated
rotein; SSNO− , nitrosopersulﬁde; Nrf2, nuclear factor (erythroid-derived 2)-like 2;
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the -transsulfuration pathway including cystathionine--synthase
(CBS), cystathionine--lyase (CSE) and 3-mercaptopyruvate sulfo-
transferase (3-MST), along with cysteine aminotransferase (CAT),
and presumed to serve a function as signaling molecule [5]. Follow-
ing nitric oxide (NO) and carbon monoxide (CO), H2S was  therefore
proposed to represent the third endogenous gasotransmitter [6].
On dissolution in aqueous media of physiological pH, as a diba-
sic acid (pKa1 ∼7, pKa2 ∼12) about two thirds of the H2S undergoes
rapid dissociation to generate hydrosulﬁde anions (HS−) and minor
amounts of the fully deprotonated dianion, S2−. Thus, a consider-
able part of the biological effects and pharmacological actions of
both, endogenous and exogenous H2S may  be mediated by HS−
rather than the uncharged (fully protonated) solute. For simplic-
ity we will here use the term ‘sulﬁde’, to deﬁne all solutes. Several
groups independently proposed that H2S signaling may be medi-
ated by sulﬁde metabolites containing a highly reactive sulfane
sulfur [7,8] such as persulﬁdes [9] and polysulﬁdes [10], and that
at least part of the biological signals are mediated by electrophilic
sulfhydration (persulﬁdation) of reactive cysteines (forming a per-
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ulﬁde (-SSH))[9–15] rather than via interaction of H2S with metals,
.g. heme-containing targets.
A further line of complexity is added by the notion that sul-
de was shown to exert similar and, in some cases, interdependent
ffects with the nitric oxide (NO) signaling pathway, in partic-
lar with regard to smooth muscle relaxation [1,4,16–18]. This
NO/H2S cross-talk’ has be shown to occur at different levels, from a
oordinated control of proteins belonging to the same signaling cas-
ade, e.g. soluble guanylate cyclase (sGC) and phosphodiesterases
16–18], over reciprocal biochemical control of activity of NO or sul-
de producing enzymes [19,20], to chemical interaction between
he two [21–24].
Nitrosopersulﬁde (SSNO−) is an S/N hybrid molecule, which has
een shown to be formed by the chemical interaction between NO-
elated species (including NO itself, NO donors and S-nitrosothiols)
ith H2S or polysulﬁdes [22–24]. Chemical and pharmacological
tudies revealed that SSNO− releases both NO and sulfane sulfur
quivalents. At low M concentrations SSNO− is a potent activa-
or of the canonical NO-receptor sGC [23,24], thereby increasing
ntracellular cGMP levels [24] and inducing vasorelaxation of pre-
onstricted aortic rings in vitro [25]; in vivo, administration of
SNO− leads to a dose-dependent decrease in mean arterial pres-
ure [24]. Considering its rather complex biological chemistry,
SNO− may  interact with biological targets other than sGC, and
his may  contribute to its overall pharmacological effects.
The transcription factor nuclear factor (erythroid-derived 2)-
ike 2 (Nrf2) is a key master redox switch ubiquitously controlling
he expression of antioxidant and protective enzymes [26–28] car-
ying an antioxidant response element (ARE, 5′-TGACTnnnGC-3′)
n its promoter [26]. The activity and stability of Nrf2, as well as
he sensitivity for its inducers is mainly regulated by the ubiquitin
igase adaptor Kelch-like ECH-associated protein(Keap)-1 [29]. It
as shown that, due to the presence of highly conserved redox-
ensitive cysteines, Keap-1 is able to sense different chemical
lasses of inducers including NO, electrophiles, heavy metals and
lkylating agents [30–32]. These redox responsive domains include
he highly-reactive Cys-151, which is responsible for sensing NO
nd nitrosative species [30,31], as well as exogenous xenobiotics
ike the canonical Nrf2 inducer tert-butylhydroquinone (tBHQ)
30]; other cysteines include Cys-288, which is the alkenal sensor,
s well as Cys-226 and Cys-613, which – together with histidine
esidues − form the Zn2+ and transition metal sensing elements
30]. Formation of a long-range disulﬁde bridge between Cys-226
nd Cys-613 was shown to be responsible for inactivation of Keap-
 by H2O2 and thereby activation of Nrf2-dependent transcription
31]. Speciﬁc substitution of these three cysteines with other amino
cids effectively abrogates the sensing properties of the Nrf2/Keap-
 system [30,31].
Sulﬁde has also been shown to activate Nrf2-dependent
esponses in vivo and contribute to cardioprotection against I/R
njury [20,33]. The molecular mechanism of sulﬁde and/or poly-
ulﬁde activation of Nrf2 is unclear at present, but seems to
nvolve direct inactivation of Keap-1 by targeting its redox sen-
itive cysteines. Lower concentrations of sulﬁde (30 M NaHS)
ere described to induce persulﬁdation of redox-sensing cysteines
ncluding Cys-151 [34], while higher concentrations of sodium
ydrosulﬁde (400 M NaHS) [35] or addition of sodium tetrasulﬁde
Na2S4; 25 M)  [14] inhibit Keap-1 by formation of a disulﬁde bond
etween Cys-226 and Cys-613, possibly via intermediate sulfhydra-
ion [35]. Taken together, these results show that the Keap-1/Nrf2
edox system is a target for sulﬁde/persulﬁde signaling.
Although SSNO− is formally considered a “nitrosated persul-
de”, it shows some peculiar characteristics: differently from
lassical persulﬁdes and polysulﬁdes it is resistant to high con-
entrations of thiols (including cysteine, glutathione and DTT)
21,23,24]. SSNO− was shown to release NO and sulfane sulfurcal Research 113 (2016) 490–499 491
on decomposition [21–24,36–38], possibly via homolysis of the
S-N bond yielding NO• and the persulﬁde radical anion, S•−. We
therefore hypothesized that SSNO− is a strong activator of the Keap-
1/Nrf2 redox system.
The aim of the present study was to investigate whether
SSNO− activates Nrf2 in cultured vascular endothelial cells. We
found that SSNO− indeed potently activates Nrf2 binding activ-
ity and increases the expression of the Nrf2 target gene heme
oxygenase (Hmox)-1 in a concentration-dependent fashion. These
results identify the Nrf2-mediated signaling pathway as a target for
nitrosopersulﬁde in cells.
2. Materials and methods
2.1. Materials
Ultrapure water (Milli-Q, Millipore),
S-nitroso-N-acetyl-D,L-penicillamine (SNAP), p-methoxyphenyl-
morpholino-phosphinodithioic acid (GYY 4137), 3-9′-xanthen]-6′-
were from Cayman Chemicals (Biomol, Hamburg, Germany).
Unless otherwise speciﬁed, all other chemicals were of the highest
purity available and purchased from Sigma-Aldrich (Schnelldorf,
Germany), cell culture plastics from Greiner (Frickenhausen,
Germany), endothelial cell culture medium and supplements from
Promocell (Heidelberg, Germany) and other cell culture material
from PAA (Pashing, Austria).
2.2. Preparation of stock solutions
Stock solutions of diethylamine NONOate (DEA/NO), spermine
NONOate (Sper/NO) and Angeli’s salt (sodium oxyhyponitrite,
Na2N2O3), all 50 mM in NaOH 0.01 M,  were prepared fresh and used
within 1–2 h. tert-butylhydroquinone (tBHQ, 50 mM in DMSO),
SNAP (200 mM,  DMSO; supersaturated), GYY4137 stocks (40 mM,
DMSO), and WSP-1 (5 mM,  DMSO) and cPTIO (50 mM,  DMSO)  were
kept aliquoted at −20 ◦C until use. Sulﬁde stock solutions (500 mM)
were prepared fresh before each experiment by dissolving anhy-
drous Na2S in Milli-Q water and further dilution in Tris buffer
(100 mM pH 7.4) immediately before use, as required. Control
measurements conﬁrmed that the pH of the cell culture medium
remained at pH 7.4 even at the highest ﬁnal target concentration.
To obtain a 1 mM stock solution of SSNO−, the reaction mixture was
prepared by adding to 795 l of 100 mM Tris buffer pH 7.4 a vol-
ume of 5 l of 200 M SNAP (ﬁnal concentration 1 mM)  and 200 l
of 50 mM Na2S (ﬁnal concentration 10 mM).  The solutions for the
control treatments with SNAP (1 mM)  or sulﬁde (10 mM)  were pre-
pared in exactly the same manner, except that sulﬁde or SNAP
were omitted. All SSNO− incubations were carried out for 10 min
under exclusion of light. To remove excess sulﬁde the stock solution
was gassed with N2 for 10 min, and removal of sulﬁde was con-
ﬁrmed by UV-visible spectrometry (see also Fig. 1A). After gassing,
the absorption band below 220 nm (corresponding to HS−) disap-
peared, while the peak at max 412 nm (corresponding to SSNO−)
was not affected by gassing. As observed previously [23,24], addi-
tion of 1 m DTT removed polysulﬁde ( = 290–350 nm) but did not
affect the peak at max 412 nm (corresponding to SSNO−).
2.3. Reaction monitoring and assessment product stability by
UV-visible spectroscopy
UV-visible spectroscopy was  used to monitor the formation
and decomposition of SSNO− from SNAP and Na2S and to con-
ﬁrm removal of excess sulﬁde employing a FLUOstar Omega
microplate reader (BMG Labtech, Ortenberg, Germany). Stock solu-
tions (100 mM)  were diluted 1:100 in 1 M TRIS pH 7.4 transferred
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Fig. 1. Activation of ARE binding by NO and sulﬁde in endothelial cells. A)
Concentration-dependent activation of Nrf2 induced by 1 hour incubations of cul-
tured human endothelial cells with the NO donors DEA/NO (100 M)  or Sper/NO
(1–100 M),  the nitrosothiol SNAP (1–100 M)  and the nitroxyl donor Angeli’s
salt (1–20 M).  n = 3–4; 1-way ANOVA p< 0.0001; Dunnett’s *p < 0.01, ***p < 0.0001.
n.s., non signiﬁcant. B) Concentration-dependent activation of Nrf2 by incuba-
tion of human endothelial cells for 1 hour with aqueous solutions of a sulﬁde
salt  (Na2S, 1–400 M)  or a sulﬁde donor (GYY4137, 10–1000 M) dissolved in
DMSO, and the corresponding vehicle control, as well as the Nrf2 activator tert-
butylhydroquinone (t-BHQ, 10 M),  which was applied as a positive control. Binding
of  Nrf2 to oligonucleotides containing the ARE sequence was  assessed by an ARE-
oligonucleotide-based ELISA. n = 3–6. 1-way ANOVA p < 0.001; Dunnett’s ** p < 0.01,
*
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(SuperSignal West Pico Chemiluminescent substrate, Thermo Fis-
cher Scientiﬁc, Oberhausen, Germany) in an ImageQuant LAS**p  < 0.001.
o a UV-transparent 96-well plate (200 l/well), and spectra were
nalyzed using Omega data analysis software (BMG Labtech).
.4. Culture of vascular endothelial cells
For all cell culture experiments pooled human umbilical vein
ndothelial cells (HUVECs; Cat No. C-12203, lot number 1110701,
romoCell) were used. HUVECs were cultured for a maximum of
wo passages in 100 mm diameter Petri dishes pre-coated with
bronectin (10 g/ml ﬁbronectin in PBS) containing 8 ml  of com-
lete endothelial growth medium with 2% fetal bovine serum
PromoCell) prepared following the manufacturer’s instruction.
ells were splitted every 3 days by using trypsin when they reached
bout 90% conﬂuence. All experiments were performed with cells
f passage 2.cal Research 113 (2016) 490–499
2.5. Assessment of cell survival by neutral red assay
Cell viability was  assessed by neutral red staining as previously
described [39,40] and expressed as the percentage of viable treated
cells vs. viable controls.
2.6. Assessment of Nrf2-binding activity from nuclear extract by
DNA-binding ELISA
Cells (106 cells/well) were cultured in 8 ml  complete endothe-
lial cell medium for 24 h. On the day of the experiment cells
were washed with PBS once, and fresh medium was  added. Treat-
ments were added directly to the cells at the ﬁnal concentrations
indicated, and cells were incubated for 1 hour at standard cul-
ture conditions. cPTIO and Cys were added to the cell supernatant
1–3 min  before addition of SSNO−. Nuclear proteins were extracted
using a Nuclear Extraction Kit (Active Motif, Carlsbad, CA) follow-
ing the manufacturer’s protocol. Brieﬂy, cells were washed, and
cellular membranes were lysed in 500 l hypotonic solution con-
taining a detergent, nuclei collected by centrifugation and lysed
at 4 ◦C by incubation for 30 min  in 50 l nuclear complete lysis
buffer on a rocking platform at 150 rpm, followed by 30 s vor-
texing at highest speed, and cleared by centrifugation at 10,000g,
4 ◦C for 10 min. Samples were rapidly aliquoted for Nrf2-binding
assay (40 l) and protein assay (5 l), frozen in liquid nitrogen and
stored at −80 ◦C. Protein concentrations of nuclear extracts were
determined according to Lowry using a commercial kit (DC Bio-
Rad Protein Assay, Bio-Rad Laboratories GmbH, Munich, Germany).
The Nrf2-binding activity of nuclear extracts was  quantiﬁed using
a commercial DNA-binding ELISA (TransAM® Nrf2, ActiveMotif, La
Hulpe, Belgium) following the manufacturer’s instructions. Brieﬂy,
nuclear proteins (10 g/well) were loaded in duplicate onto a plate
coated with ARE-oligonucleotides, and incubated for 1 h at room
temperature; after washing, Nrf2 bound to ARE was  assessed by
a colorimetric ELISA analyzing the adsorption at 450 nm.  Com-
plete nuclear lysis buffer was  used as blank, and nuclear extracts
from activated COS-7 cells transfected with Nrf2 were used as
positive controls. Percent increase in ARE binding as compared
to control was  calculated from blank subtracted absorbance as
% = (treatment-untreated control)/control.
2.7. Assessment of the Nrf2 and Nrf1 localization and nuclear
levels by Western blot analysis
Nuclear levels of Nrf2 and Nrf1 were determined by Western
blot analysis of nuclear extracts, as previously described [41,42],
and compared to the nuclear protein Lamin A. Brieﬂy, 15 g nuclear
protein extracts were loaded on a pre-cast 3–8% NuPAGE Tris-
Acetate pre-cast gels under reducing conditions, transferred onto a
PVDF membrane (GE Healthcare, Little Chalfont, UK), stained with
Ponceau S (SERVA Electrophoresis GmbH, Heidelberg, Germany)
and blocked with 5% skimmed milk in T-TBS (0.1% Tween-20
100 mM NaCl in 10 mM Tris pH 7.4) for 2 h. Membranes were incu-
bated overnight with monoclonal mouse anti-human Nrf2 (1:200;
ab62352, Abcam), monoclonal mouse anti-human Nrf1 (1:1000,
ab90524, Abcam), or anti-Lamin A (1:500, ab8980, Abcam) anti-
bodies. After washing in T-TBS bands were detected by using a
rabbit-antimouse-HRP conjugated antibody (1:5000 BD Bioscience,
New Jersey, USA) and bands were detected by chemiluminescence4000 (GE Healthcare). Bands were quantiﬁed using Image J (NIH,
Bethesda, Maryland, USA).
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.8. Assessment of SSNO− mediated increases in Hmox-1
xpression by real time RT-PCR
Endothelial cells (2 × 105 cells/well) were grown in a 6-well
late for 48 h, treated for 24 h and then lysed with 350 l RLT-lysis
uffer (RNeasy, Qiagen, Hilden, Germany). RNA concentration was
uantiﬁed using a NanoDrop ND 2000 spectrophotometer (Nano-
rop Products, Wilmington, DE, USA) and RNA quality and integrity
sing an Agilent Bioanalyser (Agilent Technology, Santa Clara, CA,
SA). After removal of genomic DNA, the RNA (1 g) was reversely
ranscribed using a MasterCycler (Eppendorf, Hamburg, Germany)
sing a QuantiTect Reverse Transcription Kit (Qiagen) containing
DNAse wipe-out buffer following manufacturer’s instructions. The
DNA (5 ng) or control RNA was used as a template for real-time
CR performed in triplicate, using TaqMan Universal PCR Master
ix  in ABI PRISM 7900 (Applied Biosystem) and Rplo as a house-
eeping gene. Primers Hmox-1 (Hs01110250 m1)  were purchased
rom Applied Biosystem, and results analyzed as described [39,40].
.9. Measurement of reduced and total glutathione (GSH)
Endothelial cells (2 × 105) were cultured in 6-well plates for
4 h, washed and treated for 24 h as described. Cells were lysed
n 200 l of ice-cold 100 mM HCl and sonicated for 30 s at 4 ◦C.
fter centrifugation at 14,000 x g for 10 minutes (min) at 4 ◦C, the
upernatant was mixed with 5% sulfosalicylic acid (2.5% ﬁnal con-
entration) to precipitate proteins, and centrifuged again. The clear
upernatant was used for GSH measurements using the DetectX
luorescent Detection Kit (Arbor Assays, Ann Arbor, MI, USA) fol-
owing the manufacturerı´s instructions, and normalized for protein
ontent assessed after buffering with 100 mM  Tris pH 7.4 using the
anoQuant kit (Carl Roth, Karlsruhe, Germany).
.10. Statistical analysis
Experiments were repeated at least three times, and all mea-
urements (except for western blot analysis) were performed in
ouble. Data are reported as means ± SEM. ANOVA followed by an
ppropriate post hoc multiple comparison test (Dunnett’s, Fisher’s
SD or Student’s T test) was used to test for statistical signiﬁcance.
 < 0.05 was considered as signiﬁcant.
. Results
.1. NO• potently activates Nrf2 in a concentration-dependent
anner, while nitrosating species (NO+ donors) and nitroxyl
HNO) are rather weak inducers of Nrf2 in vascular endothelial
ells.
In this work we sought to compare the effects of nitrososper-
ulﬁde with those of NO and sulﬁde in terms of activation of Nrf2
inding and transactivation activity in endothelial cells.
While the Nrf2 system is ubiquitously expressed, the magnitude
f the response to a stress signal and the outcome of Nrf2 acti-
ation (i.e. expression of its target genes) are strictly dependent
n tissue/cell type, cellular redox status and culture conditions. To
roperly adjust our experimental conditions for HUVECs, we tested
he responsiveness of the cellular Nrf2/Keap-1 system to tert-
utylhydroquinone (t-BHQ), a control stimulus known to inactivate
eap-1 by reacting with Cys-151 of the BTB domain [30,43]. We
ound that responsiveness and magnitude of the Nrf2 response was
trictly dependent on the source of endothelial cells (i.e. the human
onor) and strongly decreased by culturing HUVECs for more than
hree passages or maintaining cells in culture longer than 1–2 days
fter reaching conﬂuence. To conﬁrm system responsiveness and
educe batch-to-batch variability in magnitude of response, wecal Research 113 (2016) 490–499 493
worked with a deﬁned lot of HUVECs obtained by pooling different
donors and cultured the cells until passage 2 under standard-
ized culture/growing conditions (seeding, grow intervals, culturing
surface, and volume of supernatant). Under these conditions, a non-
toxic concentration of tBHQ (10 M)  increased the binding activity
of Nrf2 to ARE by 100% as compared to baseline activation level in
untreated cells (Fig. 1B).
Using this cellular system, we  ﬁrst investigated the activa-
tion of Nrf2 binding activity of nuclear extracts to ARE by a
variety of chemically related compounds including donors of NO
(100 M DEA/NO, 1–100 M Sper/NO), nitrosonium (NO+) equiva-
lents (i.e. 1–100 M of the S-nitrosothiol SNAP), and nitroxyl (HNO;
Angeli’s salt, 1–20 M AS) (Fig. 1A). We  found that both NO donors,
DEA/NO and Sper/NO strongly increased Nrf2 binding activity in
a concentration-dependent fashion (Fig. 1A). Similar, albeit less
potent effects were induced by the treatment of cells with SNAP
(20 M increased ARE binding by 25%), while equimolar concen-
trations of AS enhanced ARE binding by only 19%. This result was
unexpected, considering that S-nitrosation of Cys-151 on the BTB
domain of Keap-1 has been proposed to account for Nrf2 activa-
tion by nitrosating agents and NO [30–32]. Although mechanisms,
stoichiometry and kinetics of NO, NO+ and HNO/NO− release from
the donors applied in this study are distinct (see Discussion), pre-
venting a direct comparison of their proﬁle of activation under
standardized assay conditions, these results nevertheless show that
Nrf2 activation can be triggered by NO and nitrosothiols, but less
effectively by HNO.
3.2. Sulﬁde is a weak activator of Nrf2 in human vascular
endothelial cells
Next we aimed to compare the NO-induced enhancement of
Nrf2 binding activity to ARE to effects of sulﬁde generated from two
different sources, an inorganic sodium salt (Na2S) and the slow sul-
ﬁde releasing agent, GYY 4137. We found that concentration jumps
induced by addition of buffered sulﬁde solutions containing dis-
solved H2S (approx 25%) and hydrosulﬁde anion (HS−; approx 75%),
obtained by dissolving Na2S in aqueous buffers pH 7.4 [44], are
comparatively weak inducers of Nrf2 binding activity, as only sul-
ﬁde concentrations of 100 M and higher activated Nrf2-binding
activity by more than 20% (Fig. 1B – Na2S). Similarly, the cell-
permeable slow sulﬁde donor GYY4137 was also only a week
inducer of Nrf2 binding activity (Fig. 1B – GYY). Considering that the
corresponding vehicle control, DMSO, causes a signiﬁcant increase
in Nrf2 binding itself (Fig. 1B – 1:5 and 1:50 DMSO) the potency of
GYY 4137 to activate Nrf2 in this system is at least 10-fold lower
when compared to Na2S.
Taken together, these results demonstrate that NO is more
potent than sulﬁde in inducing Nrf2-binding activity in human
vascular endothelial cells.
3.3. Nitrosopersulﬁde increases nuclear Nrf2 levels and Nrf2
binding activity in human endothelial cells.
The chemical biology of SSNO− [23,24] suggests that SSNO−
should be a potent activator of the Keap-1/Nrf2 redox system.
SSNO− decomposition at physiological pH leads to formation of
bioactive NO [23] (as assessed by gas-phase chemiluminescence
and activation of sGC in the NO reporter cell line, RFL6) and polysul-
ﬁdes/sulfane sulfur (as assessed by UV/Vis spectrophotometry and
high-resolution mass spectrometry [23,24]). As described in detail
elsewhere [21,23], and in keeping with the chemical properties of
other persulﬁdes/polysulﬁdes [45–47], for the purpose of carrying
out biological experiments aqueous stock solutions of SSNO− have
to be prepared in situ. For the current study, SSNO− was  prepared by
reacting the nitrosothiol SNAP with a 10-fold molar excess of sulﬁde
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Fig. 2. A crude preparation of SSNO− mix  activates Nrf2 more potently than the par-
ent  compounds, SNAP and sulﬁde. A) Representative UV-visible spectra of a crude
preparation of SSNO− (1 mM;  max 412 nm), its starting compounds SNAP (max
340 nm,  1 mM)  and Na2S (max < 250 nm;  10 mM),  and a sulﬁde-free preparation of
SSNO− (1 mM;  max 412 nm)  obtained by removing excess Na2S by gassing the crude
preparation with N2. B) Concentration-dependent activation of Nrf2 in HUVECs
by crude SSNO− mix  as compared to the equivalent concentration of the starting
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Fig. 3. Sulﬁde-free SSNO− increases Nrf2 nuclear levels and ARE binding activity in
a  concentration, sulfuration and NO-dependent manner. Sulﬁde-free SSNO− prepa-
rations increase the levels of Nrf2 in the nucleus of vascular endothelial cells in
a  concentration-dependent fashion. Increases are blocked by treatment with high
concentrations of l-cysteine (Cys, 1 mM)  or the NO scavenger cPTIO (200 M).
Decomposed SSNO− does not increase nuclear Nrf2 levels. A) Representative West-
ern  blot of nuclear extract stained for Nrf2 and Nrf1. Lamin A was used as loading
control. B) Densitometric analysis of blots from three individual experiments. T-
test vs. CTRL # p < 0.05 (1-tailed). C) Sulﬁde-free SSNO− increases Nrf2 ARE-binding
activity in a concentration-dependent fashion; this activation is blocked by treat-
ment with high cysteine concentrations (Cys, 1 mM)  or the NO scavenger cPTIOaterials, SNAP and Na2S (ﬁnal concentrations of treatments added to the cells in
rackets). n = 3–7, 1-way-ANOVA p < 0.0001, Dunnett’s **p < 0.001; *** p < 0.0001.
n buffer at pH 7.4 [23]. Formation of SSNO− can be readily fol-
owed by UV-visible spectrophotometry monitoring the formation
f a new absorbance feature at max = 412 nm and disappearance
f the nitrosothiol peak at max = 340 nm until the reaction runs to
ompletion (Ref. [23]; Fig. 2A). In addition to the stable sulfur oxida-
ion products thiosulfate and sulfate, the crude reaction mixture of
SNO− (in the ﬁgures labeled as “crude SSNO−”) also contains unre-
cted sulﬁde, polysulﬁdes and the weak nitroxyl donor SULFI/NO,
s conﬁrmed by high-resolution mass spectrometry [24].
We found that crude SSNO− induces Nrf2 binding activity in
 concentration-dependent fashion (Fig. 2B), with a considerably
igher potency compared to equivalent concentrations of either
NAP or sulﬁde (compare Fig. 2B with Fig. 1A and B). The ﬁnding that
nder the same conditions 200 M and 400 M sulﬁde enhanced
rf2 binding activity by only 50% and 100%, respectively, sug-
ested this effect was not due to unreacted sulﬁde in the reaction
ixture. To unequivocally conﬁrm this assumption, we removed
xcess sulﬁde from the crude SSNO− preparations by gassing the
ully reacted mixture with N until complete disappearance of the2
ulﬁde absorption band below 220 nm (Fig. 2A; see Methods for
etails). We  found that treating HUVECs with sulﬁde-free solutions
f SSNO− (2–200 M)  increased the levels of Nrf2 as assessed by(200  M).  Decomposed SSNO− does not increase Nrf2-binding activity. n = 3, 1 way-
ANOVA, p = 0.0071, Fisher’s LSD * p < 0.05, ** p < 0.001. T-test (2 tailed) # p < 0.05.
Western blot analysis of nuclear extracts (Fig. 3A and B – lanes 2–5)
and Nrf2 binding activity (Fig. 3B – bars 2–5) in a concentration-
dependent fashion. Addition of 1 mM cysteine (L-Cys) fully blocked
SSNO− mediated increases in nuclear Nrf2 levels (Fig. 3A and B –
lane #6) and ARE binding activity (Fig. 3C, bar #6), consistent with
the likely mechanistic involvement of persulﬁde formation. Addi-
tion of the NO scavenger cPTIO also blocked both, SSNO− mediated
increases in Nrf2 levels in the nucleus (Fig. 3A and B – lane #7),
and binding activity (Fig. 3C, bar #7). Treatment of endothelial cells
with fully decomposed SSNO−, obtained by incubating the gassed
SSNO− preparation for 24 hours in the dark (see Ref. [23]) before
addition to endothelial cells, failed to increase nuclear protein lev-
els of Nrf2 (Fig. 3A,B −lane #8) and Nrf2 binding activity (Fig. 3C –
M.M. Cortese-Krott et al. / Pharmacologi
Fig. 4. Sulﬁde-free SSNO− activates Hmox-1 gene expression in a concentration and
NO-dependent manner. A 6 h incubation of HUVECs with SSNO− increases Hmox 1
mRNA levels; addition of high concentrations of l-cysteine (Cys, 1 mM)  to destroy
persulﬁde/polysulﬁdes and addition of the NO-scavenger cPTIO blocks SSNO− medi-
ated increases in Hmox-1 expression, while decomposed SSNO− does not exert any
effects. The NO donor Sper/NO increases Hmox-1 expression, while the nitrosoth-
iol  SNAP and the nitroxyl donor Angeli’s salt are considerably weaker activators
of  Hmox-1- gene expression. The Hmox-1 mRNA levels were measured by real
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aime RT-PCR and quantiﬁed vs. Rplo, which was used as housekeeping gene (n = 3,
M 1-way-ANOVA, p = 0.0177, Fisher’s LSD * p < 0.05, ** p < 0.01, T-test (2-tailed), #
 < 0.01).
ar #8). There was no signiﬁcant difference between the effects of
0 M crude SSNO− (Fig. 3A and B − lane #9 and Fig3C −bar #9)
nd that of N2-gassed SSNO− (Fig. 3A and B – lane #3 and Fig3C –
ar #), corroborating our ﬁndings that sulﬁde itself has only minor
ffects on the Keap-1/Nrf2 system in this particular cell type. More-
ver, 20 M sulﬁde-free SSNO−, which results in 76% activation of
RE binding, was more potent in activating Nrf2 binding activity
han equimolar concentrations of 20 M SNAP; this is consistent
ith lower levels of stimulation of Nrf2 binding by 20 M of either
per/NO or Angeli’s salt, as shown in Fig. 1A. Importantly, SSNO−
id not affect nuclear Nrf1 levels as assessed by Western blot anal-
sis of the same nuclear extracts (Fig. 3A), indicating that changes
n ARE binding described here were dependent on increases in Nrf2
nd not Nrf1 nuclear levels.
Taken together these results show that SSNO− is a potent activa-
or of Nrf2 in human endothelial cells the action of which appears
o depend on both, the release of NO and sulfuration of a reactive
ysteine on Keap1.
.4. Nitrosopersulﬁde increases expressional levels of the
rf2-target gene heme oxygenase 1 in human endothelial cells.
We  ﬁnally aimed to verify whether SSNO− also stimulated Nrf2
ransactivation levels by quantifying the level of expression of the
rf2 target gene, Hmox-1. The incubation time was chosen accord-
ng to previous analyses of time-depended regulation of Hmox-1
RNA in response to NO [39] and other Nrf2 inducers like zinc [40].
e found that incubation of vascular endothelial cells for 6 hours
ith SSNO− strongly and concentration-dependently (2–200 M)
ncreased the levels of Hmox-1 mRNA (Fig. 4 – treatments #2 to
5). As seen for nuclear Nrf2 expression and ARE binding, treat-
ent with high concentrations of L-Cys (1 mM,  Fig. 4 – treatment
6) or the NO scavenger cPTIO (200 M,  Fig. 4 – treatment #7) fully
locked SSNO− mediated activation of Hmox-1 gene expression,
nd treatment with 20 M decomposed SSNO− failed to stimulatecal Research 113 (2016) 490–499 495
Hmox-1 expression (Fig. 4 – treatment #8). By contrast, treat-
ment of endothelial cells with crude SSNO− signiﬁcantly increased
Hmox-1 mRNA levels (20 M;  Fig. 4 – treatment #9), and the
extent of this stimulation did not differ from that using equimo-
lar concentrations of sulﬁde-free SSNO− (20 M;  Fig. 4 – treatment
#9). At variance with the results on Nrf2 binding activity, SSNO−
(20 M)  was equipotent to Sper/NO (20 M)  in inducing expres-
sion of Hmox-1, probably a result of the well-known stabilization
of Hmox-1 mRNA by NO [48].
Taken together, our results demonstrate that SSNO− activates
Nrf2 translocation into the nucleus, Nrf2-binding activity and
expression of Hmox-1 in endothelial cells, identifying Nrf2 as an
additional target for SSNO− bioactivity in cells.
4. Discussion
The Keap-1/Nrf2 redox system was  previously shown to be
targeted by NO and nitrosating species [30–32] as well as by sul-
ﬁde and polysulﬁde [14,34,35,49], and is thought to account for
part of the pharmacological responses to donors of these species.
The S/N-hybrid, nitrosopersulﬁde (SSNO−) recently emerged as a
major reaction product of the interaction between NO/NO donors
and sulﬁde [24]. This compound has a rather peculiar chemistry,
generating both free NO and sulfane sulfur upon decomposition
[24]. In the present study we sought to investigate whether SSNO−
itself may also be an activator of the Keap-1/Nrf2 system by com-
paring its effects with those of its precursors NO and sulﬁde in
terms of activation of Nrf2 binding and transactivation activity in
human endothelial cells. We here demonstrate that 1. both, NO
and sulﬁde activate Nrf2 binding activity in cultured endothelial
cells, with donors of different redox forms of NO showing dif-
ferent activation proﬁles; 2. SSNO− increases Nrf2 nuclear levels,
Nrf2-binding and transactivation activity, and expression of the
Nrf2 downstream target Hmox-1 more potently than its precursors,
NO and sulﬁde; and 3. SSNO− induced Nrf2 transactivation activ-
ity was  blocked by both, NO scavenging (cPTIO) and inhibition of
persulﬁdation reactions (high thiol concentrations), indicating that
persulﬁde and/or polysulﬁde generation and NO reactivity may be
involved in Nrf2 activation by SSNO−. Taken together, our studies
imply that the Keap-1/Nrf2 redox system is another biological tar-
get of SSNO−, thus adding ‘stress signaling’ to the bioactivity proﬁle
of this vasodilatory molecule.
4.1. Nitrosopersulﬁde as activator of the Keap-1/Nrf2 redox
system
SSNO− was discovered and fully characterized many years ago
by Seel et al. as a product of the interaction of either sulfur or poly-
sulﬁdes with nitrite in polar organic solvents, but also identiﬁed as
a product of the reaction between gaseous NO and sulﬁde (or poly-
sulﬁde) in polar organic solvents and anaerobic alkaline aqueous
solutions [21]. Of note, Seel observed that decomposition of SSNO−
leads to release of NO into the headspace and generation of either
polysulﬁdes in solution and/or sulfur precipitation. Re-introducing
NO to these solutions again forms SSNO− suggesting that SSNO−
was in equilibrium with NO and S3•− and S4•− polysulﬁde radicals
[21]. Subsequent work by others revealed that SSNO− is also gener-
ated in the course of the reaction between nitrosothiols and sulﬁde
under both aqueous [23,24,50] and non-aqueous conditions [22].
If prepared in buffered aqueous solution, SSNO− was found to
be rather stable at physiological pH (t½ >30 min  at RT; [21–24]);
unexpectedly, its stability was neither affected by the presence of
excess sulﬁde nor by the addition of other reduced thiols (tested
for glutathione and cysteine, both at 1 mM;  [23] or DTT [23,24]).
Its decomposition at physiological pH leads to formation of NO,
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s assessed by gas phase chemiluminescence [23,24], and forma-
ion of polysulﬁdes in solution [24]. In contrast to SSNO− itself the
olysulﬁdes generated are susceptible to decomposition by dithio-
hreitol (DTT, 1 mM)  [23,24]. These properties are in line with those
bserved by Seel et al. (see discussion in Ref. [21]) and by Victor [36]
ho studied the behavior of SSNO− salts in organic polar solvents.
Assuming homolytic cleavage of SSNO−, the most likely initial
roduct formed in addition to NO is the persulﬁde radical, SS•−
Eq. (1)). Dimerization and reaction with excess thiolate may  give
ise to formation of higher polysulﬁdes (Sx2−; RSSxH). In aqueous
olution at pH 7.4, this is followed by hydrolysis and disproportion-
tion reactions [51], yielding polysulﬁdes of varying chain lengths
n addition to free H2S (Eq. (2)).
NSS− NO• + SS•− (1)
S•− → S42− → (Sx2−) H2o
→
S(x−1)2− + H2S (2)
The decomposition products of SSNO− are well-known activa-
ors of the Keap-1/Nrf2 redox system, including NO, sulﬁde, sulfane
ulfur radicals and polysulﬁde. The sensitivity of this system for NO
nd sulﬁde/sulfane sulfur is due to the presence of highly conserved
ysteines on Keap-1 [30,31,43], as demonstrated by site directed
utagenesis. However, how exactly these residues are modiﬁed
y the action of reactive nitrogen and sulfur species is not fully
nderstood. The highly-reactive Cys-151 on Keap-1 is responsible
or sensing of NO and nitrosative species via S-nitrosation [30,31].
f interest, Cys-151 was also shown to be targeted by sulﬁde-
ediated persulﬁdation in mesenchymal embryonic ﬁbroblasts
reated with moderate concentrations of sulﬁde (30 M NaHS) [34].
y exposing the same cell type to higher concentrations of sulﬁde
400 M NaHS) others proposed that Cys-151 was not involved in
ulﬁde-mediated Keap-1 inactivation; instead they observed that
ulﬁde induced formation of Keap-1 dimers via formation of a long-
ange disulﬁde bridge between Cys-226 and Cys-613, which was
receded by transient persuﬁdation of one of these cysteines [35].
ormation of Keap-1 dimers is typically observed after treatments
f cells with H2O2 [31]; since addition of catalase inhibited the
ffects of high concentrations of sulﬁde [35], the authors of this
tudy concluded that sulﬁde-induced H2O2 formation was  involved
n Keap-1 inhibition under these conditions. Both groups veriﬁed
he involvement of Cys-151 or Cys-226/Cy-613 in the inhibition of
eap-1 by sulﬁde using site-directed mutagenesis [31,35], suggest-
ng that the concentration of sulﬁde rather than other experimental
onditions were responsible for the discordance in results. Interest-
ngly, treatment of neuroblastoma cells with polysulﬁdes (25 M
a2S4) also induced formation of Keap-1 dimers [14]. It is there-
ore tempting to speculate that oxidation of Cys-226/Cy-613 in
eap-1 by high sulﬁde concentrations, as described in Ref. [35],
s secondary to the formation of polysulﬁdes in the cells and/or
olysulﬁde contamination of the NaHS solution. This mechanism
hares similarity with the activation of transient receptor potential
TRP)A1 channels, another biological target of polysulﬁdes involved
n the transmission of pain signals, in which two cysteine residues
f the amino terminus are targeted, as shown by site-directed
utagenesis [10,15]. Kimura et al. observed that polysulﬁdes are
onsiderably more potent activators of the TRPA1 channel than
ulﬁde itself, and concluded that the former are the signaling enti-
ies responsible for the effects of sulﬁde [15]; similar results were
eported for another thiol-rich protein PTEN by another group [52].
An important observation of the present study is that SSNO−
s more potent than its parent/precursor compounds NO and
ulﬁde in inducing Nrf2 accumulation into the nucleus, Nrf2
inding activity and Nrf2-mediated transactivation of the Hmox-
 gene, regardless of whether equimolar concentrations of NO
onor, nitrosothiol or nitroxyl were compared. These effects were
bserved without causing overt signs of toxicity or inducingcal Research 113 (2016) 490–499
changes in cellular GSH/GSSG redox status (see Supplementary
information Fig. S1). This may  be simply due to a different biological
chemistry of SSNO− as compared to NO and sulﬁde. Alternatively,
the higher potency of SSNO− in activating the Keap-1/Nrf2 redox
system may  be a result of concomitant release of both NOand
SS−/Sx− (according to Eqs. (1) and (2)), which are potent inhibitors
of Keap-1 and activators of Nrf2-mediated response. As a result,
SSNO− may  be considered a sulfane sulfur/NO donor hybrid with
a dual pharmacological activity on systems able to sense both
persulﬁdes/polysulﬁdes and NO. In fact, we found that treatment
with the NO scavenger cPTIO as well as inhibition of persulﬁda-
tion by treatment with high concentrations of cysteine abrogates
SSNO− – dependent activation of the Keap-1/Nrf2 redox system and
consecutive Hmox-1 expression. As demonstrated earlier, addi-
tion of high concentrations of reduced biological thiols (cysteine
and glutathione) or DTT did not affect the decomposition kinet-
ics of SSNO− [23,24], excluding an effect of cysteine on stability
of SSNO−. A clear limitation of the present study is that we can-
not meaningfully compare the pharmacological effects of SSNO−
preparations with polysulﬁde mixtures obtained by dissolving a
small-chain polysulﬁde (like Na2S3 or Na2S4) in water, buffer or
cell culture medium. Preparations of polysulﬁdes undergo rapid
disproportionation reactions yielding different equilibrium pro-
portions depending on the conditions, and on the presence of other
reactants, as for example NO, sulﬁte or SULFI/NO in the SSNO−
preparation [24], as discussed below. The resulting ﬂuxes and spe-
ciation of polysulﬁdes in aqueous solution can neither be predicted
with any degree of accuracy nor can it be reliably quantiﬁed at
present.
Nevertheless, the effects of SSNO− are consistent across all levels
of the Keap-1/Nrf2 redox system, including Nrf2 accumulation, Nrf2
binding and Hmox-1 mRNA levels, with one exception: while the
NO scavenger cPTIO potently inhibits SSNO−-mediated increases
of mRNA levels, its effects on Nrf2-binding activity are weak. This
may  be due to stronger effects of SS−/polysulﬁdes as compared to
NO on Nrf2 binding activity, or be related to the stabilization effects
of NO on mRNA levels of Hmox-1 [48]. The latter is consistent with
the observation that the effects of SSNO− on Nrf2 binding activ-
ity are stronger than those of Sper/NO, but equipotent to Sper/NO
in elevating Hmox-1 mRNA. Since cPTIO efﬁciently converts NO
to NO2, this also indicates that NO2 (a potential O2/NO reaction
product) is not responsible for Nrf2 activation under the condi-
tions analyzed in this study. This may be signiﬁcant since NO2 is
deﬁnitely a strong enough oxidant to modify thiols in Keap-1. Our
observation that DMSO (which was used as a vehicle to prepare
cPTIO stock solutions) increases Nrf2-binding activity on its own
is a potential confounder. Future analysis of cysteine modiﬁcations
on Keap-1 by biotin switch assay followed by mass spectrometric
analysis, accompanied by the use of site-directed mutagenesis will
reveal whether SSNO− induces nitrosative or sulfurative modiﬁca-
tions or leads to oxidation/disulﬁde formation of the redox-reactive
cysteines of Keap-1.
Similar to the metastable nature of short-chain polysulﬁdes and
persulﬁdes in aqueous solution [45–47], the chemistry and phar-
macology of SSNO− can only be studied if this species is generated
in situ in this medium. In the present study we prepared SSNO−
by reacting the nitrosothiol SNAP with sulﬁde at a 1:10 molar
ratio, followed by removal of excess sulﬁde by gassing with nitro-
gen [23,24]; the reaction was  carefully characterized previously by
applying independent analytical methods [24]. As demonstrated by
high-resolution mass spectrometry earlier, the reaction between
NO or nitrosothiols with excess sulﬁde leads not only to the forma-
tion of SSNO− and persulﬁde/polysuﬁdes (Eqs. (1) and (2)) but also
to production of dinitrososulﬁte [24], a molecule belonging to the
class of NONOates (also known as SULFI/NO in the literature). This
molecule was found to be a weak NO donor and a weak nitroxyl
cologi
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onor, and its main decomposition products are N2O and sulfate
24]. Although we expected that nitroxyl (HNO) might be a potent
ctivator of the Keap-1/Nrf2 system by targeting the redox-active
yteines of Keap-1, we  found that the prototypical nitroxyl donor
ngeli’s salt only elicited a relatively weak increase in Nrf2-binding
ctivity and Hmox-1 expression compared to NO. These ﬁndings
mply that SULFI/NO-derived nitroxyl present in the SSNO− reac-
ion mixture employed in the current study is unlikely to have
ontributed signiﬁcantly to the observed elevation of Nrf2 binding
ctivity and Hmox-1 expression.
The NO sensing element of Keap-1 (Cys-151) is located in the
icinity of basic amino acids, reducing the pKa of its sulfhydryl
oiety [30]; under physiological conditions, Cys-151 is therefore
xpected to exist largely in the thiolate form [30,35] and be more
rone to modiﬁcation by electrophiles such as nitrosothiols. By con-
rast, NO cannot react directly with thiolates. We  were therefore
xpecting SNAP to be a more potent activator of the Keap-1/Nrf2
ystem than SSNO− or the NO donors DEA/NO and Sper/NO. How-
ver, this was not what we found using cultured human endothelial
ells. By way of reference, S-nitrosation of Keap-1 was previously
chieved by treating pC12 cells with 500 M SNAP (32) or HeLa
ells with 500 M CysNO [31], while treatment with 2 mM Sper/NO
nduced Keap-1 dimer formation but not nitrosation of Keap-1 [31];
y contrast, another study found that Cys-151 was modiﬁed by
reatment with (a cell-membrane permeable) DEA/NO in COS1 cells
30].
In this context, it is important to point out that the potency of
ctivation of the Keap-1/Nrf2 redox system by SSNO−, SNAP and
O donors cannot be readily compared on the basis of molar con-
entrations alone. In fact, mechanisms, stoichiometry and kinetics
f NO release and/or nitrosation by each of these donors differ
arkedly [53]. At neutral pH, NONOates release NO spontaneously,
nd the kinetics of NO release is strictly dependent on the struc-
ure of the amine backbone [54]. Nitrosothiols may  release NO by
omolytic cleavage of the S N bond, a reaction which is favored in
he presence of transition metals, or participate in transnitrosation
eactions (formally, transfer of a NO+ equivalent) [21]. However,
he stability of their S N bond in biological systems is not easily
redictable and depends not only on the chemical structure of the
itrosated thiol, but also on the presence of transition metals in cul-
ure media, cellular redox status and other factors. Which factors
ontribute to homolysis of the S N bond in SSNO− is poorly under-
tood. Nevertheless, SSNO− appears to be a powerful activator of
he Keap-1/Nrf2 redox system.
.2. Is the Keap-1/Nrf2 pathways a possible target of endogenous
SNO− formation?
According to the results presented in this and earlier stud-
es SSNO− displays broad in vitro and in vivo pharmacological
ctivity. An obvious question is whether SSNO− can actually be
ormed in cells, and if so, by what mechanism. Similar discussions
rose two decades ago when peroxynitrite (OONO−) – the oxy-
en analogue of SSNO− – was shown for the ﬁrst time to have
harmacological/toxicological activity and was proposed to be of
iological relevance [55]. Peroxynitrite is formed according to a
adical-radical reaction between O2•− and NO at a rate close to the
iffusion-controlled limit (Eq. (3)) [55].
2
•− + NO• → −OONO (3)
At ﬁrst, OONO− was considered to be too unstable to be of much
elevance to biology and unlikely to be formed in tissues, not least
ecause of the presence of superoxide dismutase removing the pre-
ursor O2•− by catalyzing one of the fastest reactions known at that
ime [56–58]. Following the discovery of several different enzy-
atic sources (including NADPH oxidases and uncoupled nitriccal Research 113 (2016) 490–499 497
oxide synthase itself) forming O2•− in close proximity to enzymati-
cally generated NO from NO synthase, OONO− is now an established
cellular mediator contributing either to oxidant signaling or to “the
dark side” of NO, in particular under inﬂammatory conditions [58].
Interestingly, recent data also show that low concentrations of per-
oxynitrite induce Nrf2, potentially conferring cell protection [59].
According to Eq. (1), SSNO− is in equilibrium with its products of
homolysis, S2•− and NO. We therefore recently speculated that in
biological environments SSNO− may  be formed by a radical-radical
reaction between S2•− and NO according to the following reaction
[21]:
S2•− + NO• → −SSNO (4)
Therefore, an important question to address is then whether
the precursors of SSNO− can be found in the cellular environment.
The disulﬁde radical ion S2•− is a well-known species that can be
formed in aqueous environments by non-enzymatic and enzymatic
reactions involving polysulﬁdes and persulﬁdes [60,61]. Possible
precursors of S2•− are cysteine persulﬁde (CySSH) and glutathione
persulﬁde (GSSH) [62], which have been found in micromolar
concentrations in tissues [9], and proposed to be formed in cells
from cystine or GSSG by enzymes involved in sulfur amino acid
metabolism, including CBS, CSE [9]. According to kinetic analyses
and computer modeling, others predicted that the major products
of CBS and CSE in the reducing environment of the cell should be
sulﬁde and mixed polysulﬁdes, while CySSH was proposed to be
unstable under these conditions [63]. These ﬁndings are at vari-
ance with the experimental data demonstrating the presence of
rather high concentrations of CySSH and GSSH in cells [9]. Inter-
estingly, MST  was  reported to produce polysulﬁdes [64], which
may  generate S2•− by homolytic cleavage (inverse of Eq. (2)). Other
sources of S2•− and persulﬁde may  be the mitochondria, in partic-
ular the mitochondrial sulﬁde:quinone reductase (SQR) as well as
red blood cells via the hemoglobin-mediated oxidation of sulfur-
centered radicals [65]. Since the kinetics of most radical-radical
reactions are typically very fast, we  propose that SSNO− might be
formed in cells and tissues where sources for its precursors are
found in close proximity to each other. A challenge in this ﬁeld is
ﬁnding detection methods capable of determining concentrations
and ﬂux rates of S2•− and SSNO− at low physiological levels in cells
and tissues without perturbing natural equilibria.
5. Summary and conclusion
The Keap-1/Nrf2 redox system evolved to adapt and respond
to environmental insults, including alkenals, reactive species, and
heavy metals [30]. During its evolution some of the stimuli, includ-
ing reactive species and Zn2+ became signaling molecules and
“messengers”, and therefore the system itself became an integral
part of eukaryotic cellular signaling as both the target (Keap-1)
and effector (Nrf2) of these new messengers. Keap-1 is able to
detect the activators via speciﬁc redox-sensing cysteines and reg-
ulate the effector Nrf2 by ﬁne-tuning its localization, stability and
activity to transcriptionally activate a battery of downstream tar-
gets involved in cellular defense. In addition to protecting against
injury, a lesser-known function of the Nrf2 signaling system is to
adjust the cellular metabolic machinery to nutritional stresses [66].
Earlier work showed that NO, sulﬁde and polysulﬁdes can all acti-
vate the Keap-1/Nrf2 redox system. Here we  show that SSNO−, a
molecule emerging as a product of the chemical cross-talk between
NO and sulﬁde, itself potently activates the Keap-1/Nrf2 redox sys-
tem, leading to Nrf2 accumulation in the nucleus, increasing Nrf2
binding activity and transactivation capacity. These effects appear
to be mediated by a dual effect of the product of SSNO− decom-
position, i.e. NO and per/polysulﬁde. These results imply that the
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eap-1/Nrf2 redox system is a target of SSNO−, adding redox sig-
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